Viejo, 2018 [19] |
Spain |
February–April 2017 |
The general adult population living in the health area of Callosa D’En Sarrià |
47.5 (−) |
2637 |
1.14 (0.73–1.55) |
High risk |
Lavin, 2017 [20] |
Spain |
2015–2016 |
Spanish adult population |
– |
6839 |
1.11 (−) |
Low risk |
Quesada, 2015 [21] |
Spain |
1994–2005 |
Women from the general population in different geographical areas worldwide |
40.0(15.6) |
314 |
0.60 (0.20–2.50) |
High risk |
Andriulli, 2018 [22] |
Italy |
2015 |
The general population |
– |
4907 |
2.30 (−) |
Low risk |
Morisco, 2017 [23] |
Italy |
May 14 |
A random 1:3 systematic sample of the adult general population of Naples |
49.9(5.00) |
1315 |
3.00 (2.10–4.00) |
Low risk |
Walewska-Zielecka, 2017 [24] |
Poland |
2004–2014 |
Patients who had been tested for anti-HCV at least once in the period from 2004 to 2014 |
34.4(8.6) |
61805 |
1.50 (−) |
High risk |
Clifford, 2017 [25] |
Poland |
2004–2009 |
The general female population |
37.0(−) |
909 |
0.80 (0.30–1.60) |
High risk |
Garvey, 2017 [26] |
Ireland |
April–June 2014 and November 2015–February 2016 |
The adult population in Ireland with probability proportional to the general population age-sex distribution |
– |
3759 |
0.98 (−) |
Low risk |
Chlibek, 2017 [27] |
Czech Republic |
February 2015–September 2015 |
The adult general population |
47.1(17.1) |
3000 |
1.67 (1.27–2.19) |
High risk |
Carvalhana, 2016 [28] |
Portugal |
April 2012–December 2014 |
Adults from primary care settings in mainland Portugal |
50.2(18.3) |
1627 |
0.54 (0.20–0.90) |
Low risk |
Plompen, 2015 [29] |
Netherland |
− |
The general Dutch elderly population |
69.5(9.0) |
6036 |
0.56 (−) |
High risk |